BACKGROUND: The mesolimbic dopamine (DA) system is implicated in the development and maintenance of alcohol drinking; however, the exact mechanisms by which DA regulates human alcohol consumption are unclear. This study assessed the distinct effects of alcohol-related cues and alcohol administration on striatal DA release in healthy humans. METHODS: Subjects underwent 3 PET scans with [(11)C]raclopride (RAC). Subjects were informed that they would receive either an IV Ringer's lactate infusion or an alcohol (EtOH) infusion during scanning, with naturalistic visual and olfactory cues indicating which infusion would occur. Scans were acquired in the following sequence: (1) Baseline Scan: Neutral cues predicting a Ringer's lactate infusion, (2) CUES Scan: Alcohol-related cues predicting alcohol infusion in a Ringer's lactate solution, but with alcohol infusion after scanning to isolate the effects of cues, and (3) EtOH Scan: Neutral cues predicting Ringer's, but with alcohol infusion during scanning (to isolate the effects of alcohol without confounding expectation or craving). RESULTS: Relative to baseline, striatal DA concentration decreased during CUES, but increased during EtOH. CONCLUSION: While the results appear inconsistent with some animal experiments showing dopaminergic responses to alcohol's conditioned cues, they can be understood in the context of the hypothesized role of the striatum in reward prediction error, and of animal studies showing that midbrain dopamine neurons decrease and increase firing rates during negative and positive prediction errors, respectively. We believe that our data are the first in humans to demonstrate such changes in striatal DA during reward prediction error.
BACKGROUND: The mesolimbicdopamine (DA) system is implicated in the development and maintenance of alcohol drinking; however, the exact mechanisms by which DA regulates humanalcohol consumption are unclear. This study assessed the distinct effects of alcohol-related cues and alcohol administration on striatal DA release in healthy humans. METHODS: Subjects underwent 3 PET scans with [(11)C]raclopride (RAC). Subjects were informed that they would receive either an IV Ringer's lactate infusion or an alcohol (EtOH) infusion during scanning, with naturalistic visual and olfactory cues indicating which infusion would occur. Scans were acquired in the following sequence: (1) Baseline Scan: Neutral cues predicting a Ringer's lactate infusion, (2) CUES Scan: Alcohol-related cues predicting alcohol infusion in a Ringer's lactate solution, but with alcohol infusion after scanning to isolate the effects of cues, and (3) EtOH Scan: Neutral cues predicting Ringer's, but with alcohol infusion during scanning (to isolate the effects of alcohol without confounding expectation or craving). RESULTS: Relative to baseline, striatal DA concentration decreased during CUES, but increased during EtOH. CONCLUSION: While the results appear inconsistent with some animal experiments showing dopaminergic responses to alcohol's conditioned cues, they can be understood in the context of the hypothesized role of the striatum in reward prediction error, and of animal studies showing that midbrain dopamine neurons decrease and increase firing rates during negative and positive prediction errors, respectively. We believe that our data are the first in humans to demonstrate such changes in striatal DA during reward prediction error.
Authors: Roberto I Melendez; Zachary A Rodd-Henricks; Eric A Engleman; Ting-Kai Li; William J McBride; James M Murphy Journal: Alcohol Clin Exp Res Date: 2002-03 Impact factor: 3.455
Authors: David A Kareken; Merav Sabri; Alexander J Radnovich; Eric Claus; Brian Foresman; Dwight Hector; Gary D Hutchins Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Dean F Wong; Hiroto Kuwabara; David J Schretlen; Katherine R Bonson; Yun Zhou; Ayon Nandi; James R Brasić; Alane S Kimes; Marika A Maris; Anil Kumar; Carlo Contoreggi; Jonathan Links; Monique Ernst; Olivier Rousset; Stephen Zukin; Anthony A Grace; Jae Sung Lee; Charles Rohde; Donald R Jasinski; Albert Gjedde; Edythe D London Journal: Neuropsychopharmacology Date: 2006-09-13 Impact factor: 7.853
Authors: Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong Journal: J Neurosci Date: 2006-06-14 Impact factor: 6.167
Authors: Raúl de la Fuente-Fernández; Anthony G Phillips; Mariangela Zamburlini; Vesna Sossi; Donald B Calne; Thomas J Ruth; A Jon Stoessl Journal: Behav Brain Res Date: 2002-11-15 Impact factor: 3.332
Authors: David A Kareken; Eric D Claus; Merav Sabri; Mario Dzemidzic; Ann E K Kosobud; Alexander J Radnovich; Dwight Hector; Vijay A Ramchandani; Sean J O'Connor; Mark Lowe; Ting-Kai Li Journal: Alcohol Clin Exp Res Date: 2004-04 Impact factor: 3.455
Authors: Veronique Bragulat; Mario Dzemidzic; Thomas Talavage; Dena Davidson; Sean J O'Connor; David A Kareken Journal: Alcohol Clin Exp Res Date: 2008-07 Impact factor: 3.455
Authors: Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li Journal: J Psychopharmacol Date: 2016-01-11 Impact factor: 4.153
Authors: Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean J O'Connor; Christine M Herring Journal: Eur J Nucl Med Mol Imaging Date: 2011-10-19 Impact factor: 9.236
Authors: Xiaosi Gu; Terry Lohrenz; Ramiro Salas; Philip R Baldwin; Alireza Soltani; Ulrich Kirk; Paul M Cinciripini; P Read Montague Journal: Proc Natl Acad Sci U S A Date: 2015-01-20 Impact factor: 11.205
Authors: Nina B L Urban; Lawrence S Kegeles; Mark Slifstein; Xiaoyan Xu; Diana Martinez; Ehab Sakr; Felipe Castillo; Tiffany Moadel; Stephanie S O'Malley; John H Krystal; Anissa Abi-Dargham Journal: Biol Psychiatry Date: 2010-08-03 Impact factor: 13.382
Authors: Sargo Aalto; Kimmo Ingman; Kati Alakurtti; Valtteri Kaasinen; Jussi Virkkala; Kjell Någren; Juha O Rinne; Harry Scheinin Journal: J Cereb Blood Flow Metab Date: 2014-12-10 Impact factor: 6.200
Authors: Brandon G Oberlin; Mario Dzemidzic; Stella M Tran; Christina M Soeurt; Daniel S Albrecht; Karmen K Yoder; David A Kareken Journal: Neuropsychopharmacology Date: 2013-04-15 Impact factor: 7.853